Literature DB >> 25655725

Controversies in the use of hydroxyethyl starch solutions in small animal emergency and critical care.

Katja N Adamik1, Ivayla D Yozova, Nadine Regenscheit.   

Abstract

OBJECTIVES: To (1) review the development and medical applications of hydroxyethyl starch (HES) solutions with particular emphasis on its physiochemical properties; (2) critically appraise the available evidence in human and veterinary medicine, and (3) evaluate the potential risks and benefits associated with their use in critically ill small animals. DATA SOURCES: Human and veterinary original research articles, scientific reviews, and textbook sources from 1950 to the present. HUMAN DATA SYNTHESIS: HES solutions have been used extensively in people for over 30 years and ever since its introduction there has been a great deal of debate over its safety and efficacy. Recently, results of seminal trials and meta-analyses showing increased risks related to kidney dysfunction and mortality in septic and critically ill patients, have led to the restriction of HES use in these patient populations by European regulatory authorities. Although the initial ban on the use of HES in Europe has been eased, proof regarding the benefits and safety profile of HES in trauma and surgical patient populations has been requested by these same European regulatory authorities. VETERINARY DATA SYNTHESIS: The veterinary literature is limited mostly to experimental studies and clinical investigations with small populations of patients with short-term end points and there is insufficient evidence to generate recommendations.
CONCLUSIONS: Currently, there are no consensus recommendations regarding the use of HES in veterinary medicine. Veterinarians and institutions affected by the HES restrictions have had to critically reassess the risks and benefits related to HES usage based on the available information and sometimes adapt their procedures and policies based on their reassessment. Meanwhile, large, prospective, randomized veterinary studies evaluating HES use are needed to achieve relevant levels of evidence to enable formulation of specific veterinary guidelines. © Veterinary Emergency and Critical Care Society 2015.

Entities:  

Keywords:  colloids; hypovolemia; safety; sepsis; side effects

Mesh:

Substances:

Year:  2015        PMID: 25655725     DOI: 10.1111/vec.12283

Source DB:  PubMed          Journal:  J Vet Emerg Crit Care (San Antonio)        ISSN: 1476-4431


  12 in total

1.  Current Trends in Volume Replacement Therapy and the Use of Synthetic Colloids in Small Animals-An Internet-Based Survey (2016).

Authors:  Ivayla D Yozova; Judith Howard; Nadja E Sigrist; Katja-Nicole Adamik
Journal:  Front Vet Sci       Date:  2017-09-04

2.  Changes in Serum Creatinine Concentration and Acute Kidney Injury (AKI) Grade in Dogs Treated with Hydroxyethyl Starch 130/0.4 From 2013 to 2015.

Authors:  N E Sigrist; N Kälin; A Dreyfus
Journal:  J Vet Intern Med       Date:  2017-01-21       Impact factor: 3.333

Review 3.  Starch Wars-New Episodes of the Saga. Changes in Regulations on Hydroxyethyl Starch in the European Union.

Authors:  Katja-Nicole Adamik; Ivayla D Yozova
Journal:  Front Vet Sci       Date:  2019-01-18

4.  Membrane-based therapeutic plasma exchange in dogs: Prescription, anticoagulation, and metabolic response.

Authors:  Thierry Francey; Ariane Schweighauser
Journal:  J Vet Intern Med       Date:  2019-05-21       Impact factor: 3.333

Review 5.  Fluid and Electrolyte Therapy During Vomiting and Diarrhea.

Authors:  Luis Tello; Rossana Perez-Freytes
Journal:  Vet Clin North Am Small Anim Pract       Date:  2016-12-08       Impact factor: 2.093

Review 6.  Intravenous Fluid Administration and the Coagulation System.

Authors:  Corrin J Boyd; Benjamin M Brainard; Lisa Smart
Journal:  Front Vet Sci       Date:  2021-04-15

7.  In vitro effects of 6 % hydroxyethyl starch 130/0.42 solution on feline whole blood coagulation measured by rotational thromboelastometry.

Authors:  Nathalie A Albrecht; Judith Howard; Alan Kovacevic; Katja N Adamik
Journal:  BMC Vet Res       Date:  2016-07-26       Impact factor: 2.741

8.  Thromboelastometric assessment of hemostasis following hydroxyethyl starch (130/0.4) administration as a constant rate infusion in hypoalbuminemic dogs.

Authors:  Angelica Botto; Barbara Bruno; Cristiana Maurella; Fulvio Riondato; Alberto Tarducci; Giulio Mengozzi; Antonio Borrelli
Journal:  BMC Vet Res       Date:  2018-01-31       Impact factor: 2.741

9.  Effects of Hydroxyethyl Starch 130/0.4 on Serum Creatinine Concentration and Development of Acute Kidney Injury in Nonazotemic Cats.

Authors:  N E Sigrist; N Kälin; A Dreyfus
Journal:  J Vet Intern Med       Date:  2017-09-01       Impact factor: 3.333

10.  Rapid exacerbation of renal function after administration of hydroxyethyl starch in a dog.

Authors:  Junwoo Bae; Mahmoud Soliman; Hyunwoo Kim; Seongwoo Kang; Woosun Kim; Soomin Ahn; Kyoungoh Cho; Jihye Choi; Suhee Kim; Jinho Park; Sangki Kim; Yoonjung DO; Jaegyu Yoo; Dohyeon Yu
Journal:  J Vet Med Sci       Date:  2017-09-02       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.